A new revolution
in treating Joint Pain
A Full Range of Motions & Emotions
Preservation
An effective
cutting edge
—
treatment for t Sahq| Therapy™
Joint Pain An Australian Patented SVF Technology
andWhatis Arthritis ?
Arthritis is chronic inflammatory progressive joint disease which refers to severe joint-
pain or joint-disease. The most common type of arthritis is Osteoarthritis (OA) and
Rheumatoid Arthritis (RA). OA affects elder people while RA affects younger age group.
Common arthritis symptoms include swelling, pain, stiffness and decreased range of
motion. Symptoms may come and go. They can be mild, moderate or severe.They may
stay about the same for years or may progress or even get worse over time. Severe
arthritis can result in chronic pain, inability to do daily activities, difficulty in walking or
climbing stairs & may even lead to complete physical immobility.
Reason of painin Arthritis
In OA, loss of cartilage / erosion (cushioning surface) causes rubbing of bones against
another causing pain, swelling and stiffness. Over time, joints can lose strength and pain
may become chronic. Excess body weight, family history, age and previous injury
increases the risk further.
STAGE OF KNEE OSTEOARTHRITIS
I W MM Vv
Doubtful Mild Moderate SevereTreatment Options
+ Medication :
Pain killers or anti-inflammatory medicines, steroids etc. long term use of these may
effect vital organs such as kidney, liver etc
+ Physiotherapy
+ Surgery : Only for grade - IV OA -
Total Knee Replacement / High Tibial Osteotomy / Partial Knee Replacement
+ Joint Preservation :
Autologous SVF grafting
Whatis Grafting ?
Grafting refers to a surgical procedure to move tissue from one site to another in the body,
orfrom another person
Classified into these two classes:
+ Autologus grafting
+ Allogeneicgrafting
Whatis Autologus Grafting?
Autologus graft is taken from one part of the body of an individual and transplanted onto
another site in the same individual
There are several type of Autologus grafting has been done surgically suchas:
+ Skin grafting
+ Bone grafting
+ Vascular grafting
+ Vascular conduit (asin bypass surgery arterial or venous graft)
+ Autologous blood component transfusion (such as plasma, concentrated platelets
extracted from whole blood)
+ Autologous SVF Grafting of Lipoaspirate adipose tissuefor arthritis
About Autologous Stromal Vascular Fraction (SVF)
SVF contains a heterogeneous mix of cells, which is known to contain adipose tissue-
derived stromal cells (ASCs), mesenchymal cells, progenitor cells, Pericytes, T-regulatory
cells, EPC (endothelial progenitor cells), anti-inflammatory M2 macrophages and many
other cell types . When fat cells (adipocytes) and the collagen that binds adipose tissue
together are removed using SVF technology, just the stromal vascular fraction (SVF) cells
remain.
SVF contains heterologous mixture of cells with growth factors thus SVF is not a
stem celltherapy.
Autologous Stromal Vascular Fraction grafting is an Australian Patented technology for
treatment of joint pains. This technology is successfully running in Australia since 2009
and thousands of patients were successfully treated there. This technology is available in
United States of America (USA) and in many more countries.
Autologus Stromal Vascular Fraction (SVF) is a type of Autologus grafting done ina single
surgical sitting which is already in use for long time with proven safety and efficacy for
treatment of Arthritis.SVF Process
In this process around 300 - 400 ml fat is aspirated from the tummy of patient under
local anesthesia then by using Australian patented technology SVF is isolated with in
50 minutes without using any enzymes, chemicals, animal products.
Then under sonography guided Autologous SVF is grafted in intra articular space
of effected joint in single surgical sitting.
In this procedure there is:
+ Nouseofany chemical,
+ Nouseofany enzymes, culture of cell
+ Nouse ofany animal product.
+ As SVF grafting is an Autologus procedure so there is no chances of rejection and
allergic reactions.
Why SVF is best choice
Autologous SVF is a one-day procedure which is safe, highly effective, painless with
maximum regeneration potential & without adverse effects & morbidity.
Itis minimally invasive & treats the underlying cause. It has proven value in remarkably
improving quality of life
Patient can go home walking the very next day. So far, there are no visible side effects
of Autologous SVF grafting is reported. It improve the quality of life by accelerating
the regeneration process in the affected area and provides biological solution for
biological problem.Yes if you have joint pain adversely affecting your daily routine,
Least invasive SVF which treats underlying cause is the ideal choice for you.
+ Osteoarthritis -OA
All Gr. |, Il, Ill and IV* with less than 15° deformity
+ Rheumatoid Arthritis - RA
+ Avascular Necrosis of Hip
Post SVF there is no vital impact on life style like
+ Patient can sit on floor
+ Can climb stairs
+ Can utilize Indian style toilets and many more.
SVF treatment is not recommended for
+ Pregnant & lactating women
+ Patients with Gout or having active infection or HIV
+ Active cancer during previous 3 years.ales
iste) E-Lecvaalal
ES
Australian
SVF Patented
Technology
ICs
Impact on bones
Mechanism
Invasion
Anesthesia
Recovery
Treatment type
Nature of
Intervention
Indication
Revision Surgery
Need for
Revision Surgery
Effect on life style
Hospitalization
Implant Rejection
Effect on Cartilage
regeneration
Effect of body
weight on outcome
Age criteria
Fitness for surgery
Choice of treatment
teu sele\eciaa ein)
Inevitable loss of bone :
Tibia, Femur & Patella
Prosthesis
Highly Invasive
General / Spinal
Extended Recovery
Artificial Implant
Mechanical
1-Grade -IVOA
2-Not suitable for RA Patients
Difficult with poor outcome
Generally required
after 10 -12 years *
Numerous restrictions
Minimum stay of 4 -5 days
Possibility
It doesn't treat the
underlying cause i.e.
cartilage degeneration
Poor result in case of
obese patients
Usually avoided for
younger patients
Patients must have
good fitness to undergo
this surgery
1-It should always be the
second choice
2 - If it fails no other
treatment is possible. Only
alternative left is revision knee
replacement surgery
“As per clinical als, Except for more than 15' deformed joint
SVF Technology
ahaj Th
Injection only hence no
bone loss
Natural Regenerative cells
Minimally Invasive
Local
Easier & Quicker
Autologous Cell
Biological
1- All Grade of OA**
2 - Suitable for RA** also
Easy
Need may not be there*
Substantial improvement
One day hospitalization
No rejection (As own cells)
It treats underlying cause by
cartilage regeneration
Equally effective for all body
weights
Suitable for all age groups
It is not a major limiting factor
1- It should be the first choice
of treatment
2 - Ifit fails other treatment
options are openLia
PRP alone vs SVF
Tela)
Source Blood Adipose Tissue
Contain Platelet reach plasma Heterogeneous mixture of cells
Effect Lasting Short lasting effect More than 5 years*
Regenerative Cells Absent Present
Mechanism Doesn't directly replace Can replace damaged cells by dividing and
damaged cells differentiating into the cell type needed
Regeneration No capability of cell Capability of continuous cell regeneration
regeneration
Quantum of Reduces with time Regeneration continues
Growth factors
PRP AloneEfficacy of Autologous SVF Grafting
Patient treated with Australian Patented Autologous SVF grafting obtained an
average of 85% improvement in pain and mobility from degenerative joint
disease. Global studies of more than a 7 years showed remarkable improvement
in joint pain, quality of life and mobility.
Unique feature of Sahaj Therapy
+ Noculture
+ Nouseofenzyme/chemical / animal product
+ Achieve more than 85% improvementin pain
+ Doneunderlocal anesthesia
+ Minimally invasive procedure
+ Treats underlying cause
+ Nosignificant adverse effect
+ Ageand body weight is nota limiting factor for patient selection
+» Norisk of disease transfer- Autologous process
For more information please contact
9 Sahaj Regenerative Cell Therapeutics LLP EE ol
15/2 South Tukoganj, Indore 452001 (M. P.) India '
(+91 731 2510 200, 252 9723, 91 82230 80555
@ wwwsahajtherapy.com ol
3 info@sahajtherapy.com
Disclaimer Most data presented in ths brochure are base on publ shel studes an outcomes of clinical teas cared ou in ferent pats ofthe worl. Heath
related information and opinions change frequently and therefore information contained in ths brochure may be outdated, incomplete or incoret. The information,
statements and images provided in this brochure ifr informational purpose only & should not substitute advice proved by the treating physician